Welcome to our dedicated page for Curaleaf Hldgs news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on Curaleaf Hldgs stock.
Curaleaf Holdings, Inc. (OTCQX: CURLF, TSX: CURA) generates frequent news as an international provider of consumer cannabis products operating across medical and adult-use markets. Company updates often highlight its portfolio of brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company, and how these brands are deployed through retail dispensaries and international channels.
News coverage for Curaleaf commonly includes corporate and regulatory developments, such as its announced intention to seek shareholder approval for a proposed arrangement to continue from British Columbia, Canada to Delaware in the United States. This proposed domestication is described by the company as a way to align its corporate structure with its operational focus while maintaining its listings on the Toronto Stock Exchange and OTCQX.
Investors and observers can also expect retail expansion and operational updates. Recent announcements have covered the opening and relocation of dispensaries, including Curaleaf Millcreek in Erie, Pennsylvania, and Curaleaf Cape Canaveral in Florida. These releases describe new store locations, in-store experience, and the availability of products such as premium flower, vapes and edibles under the company’s brands.
Curaleaf’s news flow further includes transaction and financing announcements, such as its binding commitment to acquire, and later the termination of that commitment for, The Cannabist Company’s Virginia assets, and the upsizing of its revolving credit facility with Needham Bank from $40 million to $100 million. In addition, the company issues financial results releases, including quarterly reports prepared under U.S. GAAP that detail segment revenue, margins, cash flow and non-GAAP performance measures.
Beyond financial and operational items, Curaleaf also reports on community and social initiatives like its Feed the Block fundraiser to address food insecurity and partnerships with organizations such as the Baldwin Fund. For those tracking CURLF, this news page brings together these various categories of updates in one place.
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) has announced a significant expansion of its retail operations in New York. The company is opening two new medical dispensaries in Rochester and Syracuse, and introducing co-located adult-use sales at its existing Plattsburgh and Forest Hills locations. This expansion will increase Curaleaf's total retail footprint in New York to six dispensaries, with three offering both medical and adult-use sales.
The new Curaleaf Rochester location opened on July 25, while Curaleaf Syracuse is set to open in the coming weeks, pending regulatory approval. Both new medical dispensaries will be staffed with full-time pharmacists and offer a wide range of cannabis products. The company is also hosting grand opening events to celebrate the new locations.
This expansion aligns with Curaleaf's commitment to providing access to licensed, tested cannabis products for both medical patients and adult-use consumers across New York state.
Curaleaf Holdings is set to announce its financial and operational results for Q2 2024 on August 7, 2024, after market close. The company will host a conference call and audio webcast at 5:00 p.m. ET, featuring prepared remarks and a Q&A session. Investors can join the call via various international numbers or access the webcast online. A replay will be available until August 14, 2024.
Curaleaf has announced the launch of a new hemp-derived THC product line under its Select and Zero Proof brands, available from June 26 through a new online platform, TheHempCompany.com. This initiative aims to set new industry standards for safety and quality. In addition to Curaleaf's products, the platform will feature third-party offerings that meet Curaleaf's stringent criteria. Products will be delivered directly to consumers in 25 states and the District of Columbia, starting July 1, with additional distribution through retail and on-demand delivery via DoorDash. The company emphasizes transparency, quality, and safety, with age-gated sales and clear labeling. This move is part of Curaleaf's strategy to expand its presence in the hemp-derived market and generate substantial shareholder value.
Curaleaf Holdings held its 2024 Annual General Meeting of Shareholders on June 14, 2024, via live webcast. A total of 1,741,506,378 votes were cast. Key decisions included the re-election of directors with high approval rates: Boris Jordan (98.515%), Joseph Lusardi (98.931%), Dr. Jaswinder Grover (99.906%), Karl Johansson (99.587%), Peter Derby (99.253%), Mitchell Kahn (98.736%), Shasheen Shah (99.848%), and Michelle Bodner (98.873%). Shareholders also approved the reappointment of PKF O'Connor Davies, LLP as the auditor and set the number of directors to 10. Detailed voting results are available on SEDAR+ and EDGAR.
KindlyMD announced a strategic collaboration with Curaleaf to expand medical cannabis education in Utah. The partnership aims to offer holistic pain management and alternative therapies. Community care events will be held throughout the summer at Curaleaf's medical cannabis pharmacies in Lehi, Provo, and Payson. These events aim to educate patients on medical cannabis as a safer, more affordable option for pain management. KindlyMD's Complete Care program will be introduced, offering easier access to medical cannabis care. This initiative aligns with efforts to combat the opioid crisis and promote sustainable healthcare options.
Curaleaf Holdings announced the launch of Select Fruit Stiq, a rechargeable 1G All-In-One cannabis oil vape with bold fruity flavors. The product features Berry, Citrus, and Tropical terpene blends and aims to provide a high-quality vape experience. Initially launched in Arizona, Utah, and Nevada, Select Fruit Stiq received positive feedback. Now, it's available in six flavors: Sweet Strawberry, Blackberry Blast, Lemon Sunset, Key Lime Tide, Watermelon Breeze, and Go Go Guava. The vape will expand to more states, including New Jersey, Florida, and Illinois, pending regulatory approvals, throughout the summer.
Curaleaf Holdings (CURLF), a major player in the cannabis sector, responded to the House Committee on Agriculture's approval of the Miller amendment to the 2018 Farm Bill. The amendment, introduced by Mary Miller (R-IL), aims to roll back the Farm Bill. Curaleaf's Executive Chairman, Boris Jordan, expressed disagreement with the amendment, emphasizing the company's support for hemp farmers and the importance of maintaining safety and age standards for hemp-derived products. Jordan advocated for a unified regulatory framework for all cannabinoids to combat illicit market dangers. Curaleaf remains committed to medical and adult-use cannabis consumers and community initiatives.
Curaleaf Holdings announced the opening of its Miami North Biscayne dispensary, marking its 62nd location in Florida and 146th nationwide. The dispensary, located at 2250 NE 163rd St. Suite 1, North Miami Beach, FL, opened to licensed medical patients on May 21 and will operate daily with varying hours. A grand opening is scheduled for June 1, featuring a ribbon-cutting ceremony and exclusive deals. The new store will offer a wide range of products, including Grassroots craft flower and Select Briq vapes, with plans to introduce new items pending regulatory approval. Curaleaf's loyalty program allows patients to earn points on purchases, redeemable for future savings.
Curaleaf reported first quarter 2024 revenue of $339 million, a 2% year-over-year increase, with an adjusted gross margin of 48%. Adjusted EBITDA was $77 million, representing 23% of revenue. The company ended the quarter with $105 million in cash and generated $46 million in operating cash flow and $33 million in free cash flow. Key highlights include the acquisition of Northern Green Canada, expanding market presence in Europe, and successful brand expansion in the U.S..
Summary not available.